Patent Assignment
Reel/Frame 074994/0338
Second Amended and Restated Patent Security Agreement
Recorded: 2026-03-02
Pages: 45
Assignor
UROGEN PHARMA LTD.
Executed: 2026-02-26
Assignee
BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
C/O BEAUFORT HOUSE, 51 NEW NORTH ROAD, EXETER, EX4 4EP, UNITED KINGDOM
Covered Properties
(44)
Treatment of Low-Grade Intermediate-Risk Non-Muscle-Invasive Bladder Cancer with a Thermally Gelling Pharmaceutical Composition Containing Mitomycin
Application:
18/784,354 →
Publication:
US 2025/0032409
Immunomodulating Treatments of Body Cavities
Application:
19/094,915 →
Publication:
US 2025/0221929
Oncolytic Adenovirus Compositions with Enhanced Replication Properties
Application:
19/261,101 →
Publication:
US 2026/0167940
Adenoviral Assembly Method
Application:
17/681,538 →
Publication:
US 2022/0411763
Oncolytic Adenovirus Compositions
High Throughput Assay for Measuring Adenovirus Replication Kinetics
Application:
18/809,603 →
Publication:
US 2025/0146013
Exogenous Gene Expression in Recombinant Adenovirus for Minimal Impact on Viral Kinetics
Application:
19/097,089 →
Publication:
US 2025/0382638
Tumor-Targeting Synthetic Adenoviruses and Uses Thereof
Application:
18/478,388 →
Publication:
US 2024/0207445
Selective Cell Targeting Using Adenovirus and Chemical Dimers
Application:
18/426,803 →
Publication:
US 2024/0342231
Hsv-1 Oncolytic Virus Therapies That Specifically Kill Alt Dependent Cancers
Application:
18/797,069 →
Publication:
US 2025/0134941
Biocompatible Drug Delivery Apparatus and Methods
Pharmaceutical Compositions Comprising Imidazoquinolin(Amines) and Derivatives Thereof Suitable for Local Administration
Material and Method for Treating Internal Cavities
Phospholipid Drug Analogs
Phospholipid Drug Analogs
Pharmaceutical Compositions Comprising Imidazoquinolin(Amines) and Derivatives Thereof Suitable for Local Administration
Material and Method for Treating Internal Cavities
Slow Release Formulations of Cell Cycle Regulators and Anti-Cancer Agents for Local Treatment of Solid Cancer
Patent:
9,801,854 →
Application:
14/600,354 →
Material and Method for Treating Internal Cavities
Phospholipid Drug Analogs
Material and Method for Treating Internal Cavities
Immunomodulating Treatments of Body Cavities
Material and Method for Treating Cancer
Thermosensitive Bio-Adhesive Hydrogel for Removal of Ureteral and Renal Stones
Material and Method for Treating Cancer
Material and Method for Treating Internal Cavities
Immunomodulating Treatments of Body Cavities
Material and Method for Treating Internal Cavities
Oncolytic Adenovirus with Enhanced Replication Properties Comprising Modifications in E1A, E3, and E4
Adenoviral Assembly Method
Adenoviral Assembly Method
Oncolytic Adenovirus Compositions
Oncolytic Tumor Viruses and Methods of Use
High Throughput Assay for Measuring Adenovirus Replication Kinetics
Exogenous Gene Expression in Therapeutic Adenovirus for Minimal Impact on Viral Kinetics
Exogenous Gene Expression in Recombinant Adenovirus for Minimal Impact on Viral Kinetics
Exogenous Gene Expression in Recombinant Adenovirus for Minimal Impact on Viral Kinetics
Tumor-Targeting Synthetic Adenoviruses and Uses Thereof
Adenoviral Tumor Diagnostics
Anti-Cancer Adenoviruses
Selective Cell Targeting Using Adenovirus and Chemical Dimers
Hsv-1 Oncolytic Virus Therapies That Specifically Kill Alt Dependent Cancers
Process for the Preparation of a Freeze-Dried Pharmaceutical Composition Containing Mitomycin C
Process for the Preparation of a Freeze-Dried Pharmaceutical Composition Containing Mitomycin C
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 16, 2004
From: HOLZER, ASHER; DANIEL, DORIT; HIRSZOWICZ, ERAN
To: THERACOAT LTD.
Reel/Frame 015817/0081 →
Assignment of Assignor's Interest
Sep 14, 2011
From: LEONI, LORENZO; MAJ, ROBERTO; PATTARINO, FRANCO; VECCHIO, CARLO
To: TELORMEDIX SA
Reel/Frame 026906/0392 →
Assignment of Assignor's Interest
Nov 5, 2012
From: HOLZER, ASHER; DANIEL, DORIT; MULLERAD, MICHAEL; DE LA ZERDA, JAIME
To: THERACOAT LTD.
Reel/Frame 029238/0909 →
Assignment of Assignor's Interest
Jun 20, 2013
From: MAJ, ROBERTO; PATTARINO, FRANCO; MURA, EMANUELA; BARBERIS, ALCIDE
To: TELORMEDIX SA
Reel/Frame 030655/0891 →
Assignment of Assignor's Interest
Nov 3, 2013
From: LEONI, LORENZO; MAJ, ROBERTO; PATTARINO, FRANCO; VECCHIO, CARLO
To: TELORMEDIX SA
Reel/Frame 031533/0541 →
Assignment of Assignor's Interest
Jan 9, 2014
From: KONORTY, MARINA; HAKIM, GIL
To: THERACOAT LTD
Reel/Frame 031947/0586 →
Assignment of Assignor's Interest
Oct 27, 2015
From: MAJ, ROBERT; PATTARINO, FRANCO; MURA, EMANUELA; BARBERIS, ALCIDE
To: TELORMEDIX SA
Reel/Frame 036895/0721 →
Asset Purchase Agreement
Nov 13, 2015
From: TELORMEDIX SA
To: THERACOAT LTD.
Reel/Frame 037109/0769 →
Change of Name
Nov 13, 2015
From: THERACOAT LTD
To: UROGEN PHARMA LTD
Reel/Frame 037111/0567 →
Change of Name
Nov 24, 2015
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 037135/0053 →
Change of Name
Jan 19, 2016
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 037553/0678 →
Assignment of Assignor's Interest
Feb 4, 2016
From: TELORMEDIX, SA
To: UROGEN PHARMA LTD.
Reel/Frame 037668/0353 →
Change of Name
Jan 8, 2018
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 045016/0287 →
Assignment of Assignor's Interest
Jan 8, 2018
From: HOLZER, ASHER; DANIEL, DORIT; MULLERAD, MICHAEL; DE LA ZERDA, JAIME
To: THERACOAT LTD.
Reel/Frame 044556/0637 →
Change of Name
Mar 15, 2021
From: THERACOAT LTD.
To: UROGEN PHARMA LTD.
Reel/Frame 055588/0095 →
Security Interest
Apr 8, 2021
From: UROGEN PHARMA LTD.
To: RTW INVESTMENTS ICAV
Reel/Frame 055868/0385 →
Assignment of Assignor's Interest
Jul 12, 2021
From: O'SHEA, CLODAGH; MIYAKE-STONER, SHIGEKI
To: SALK INSTITUTE FOR BIOLOGICAL STUDIES
Reel/Frame 056830/0176 →
Assignment of Assignor's Interest
Feb 25, 2022
From: O'SHEA, CLODAGH; POWERS, COLIN
To: SALK INSTITUTE FOR BIOLOGICAL STUDIES
Reel/Frame 059107/0939 →
Security Interest
Mar 18, 2022
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 059302/0501 →
Amended and Restated Patent Security Agreement
May 19, 2022
From: UROGEN PHARMA LTD.
To: RTW INVESTMENTS ICA V
Reel/Frame 060121/0591 →
Assignment of Assignor's Interest
Oct 2, 2023
From: O'SHEA, CLODAGH; POWERS, COLIN; ZHANG, LEI
To: SALK INSTITUTE FOR BIOLOGICAL STUDIES
Reel/Frame 065088/0382 →
Patent Security Agreement
Mar 18, 2024
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC
Reel/Frame 066805/0346 →
Assignment of Assignor's Interest
Aug 9, 2024
From: O'SHEA, CLODAGH; DEHART, JASON
To: SALK INSTITUTE FOR BIOLOGICAL STUDIES
Reel/Frame 068240/0293 →
Assignment of Assignor's Interest
Aug 20, 2024
From: O'SHEA, CLODAGH; PARTLO, WILLIAM; POWERS, COLIN
To: SALK INSTITUTE FOR BIOLOGICAL STUDIES
Reel/Frame 068340/0673 →
Amended and Restated Patent Security Agreement
Mar 6, 2025
From: UROGEN PHARMA LTD.
To: BIOPHARMA CREDIT PLC [COLLATERAL AGENT]
Reel/Frame 070434/0319 →